drugset / Trial / NCT05366231
Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)
RandomizedParallel-groupSingle-blindTreatment
Summary
This trial is an exploratory study, aiming to explore the preliminary efficacy and safety of Kesuting Syrup in the treatment of novel coronavirus pneumonia. It is planned to include a total of 200 cases. Kesuting Syrup test group: Lianhua Qingwen Granules control group = 1:1, each 100 cases in each group.
Timeline
- Start
- 2022-05-08
- Primary completion
- 2022-09-15
- Completion
- 2022-09-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Kesuting syrup | Unknown | 20 ml | Oral |
| Comparator | LianHuaQingWen Granules | Unknown | 1 unknown | Oral |